Ganfeng Lithium Co., Ltd. (002460.SZ)
Xinyu, CN
Ganfeng Lithium Co., Ltd., established in 2000 and headquartered in Xinyu, China, is a global leader in the production and distribution of diverse lithium products. The company's market reach extends across mainland China, the broader Asian region, the European Union, North America, and other international territories. Its operations are organized into three core divisions: Lithium Metal and Compound, Lithium Battery, and Lithium Ore Resource and Related Activities. Ganfeng maintains a substantial portfolio of lithium resource projects worldwide. These include the Mount Marion mine and the Pilbara Pilgangoora lithium-tantalum project in Australia; the Cauchari-Olaroz and Mariana projects in Argentina; the Sonora project in Mexico; the Ningdu Heyuan mine and Qinghai Yiliping lithium salt lake project in China; the Avalonia project in Ireland; and the Goulamina spodumene ore project in Mali, Africa. The company's extensive product line encompasses various high-purity lithium compounds such as battery-grade lithium hydroxide, lithium carbonate, lithium chloride, butyl lithium, and lithium fluoride. It also manufactures lithium metals in diverse forms, including ingots, foils, rods, particles, and alloy powders. Within its battery segment, Ganfeng develops polymer lithium batteries, along with lithium-ion batteries tailored for motive power, energy storage, and consumer applications, as well as specialized copper lithium or lithium aluminum alloy foils. Beyond manufacturing, Ganfeng Lithium actively engages in the exploration and commercialization of lithium ores and offers comprehensive lithium battery recycling solutions. Its exported products serve as crucial components across numerous industries, finding widespread application in electric vehicles, portable electronic devices, chemical manufacturing, and pharmaceutical production. The company's broad customer base includes producers of battery cathode materials, battery suppliers, and automotive original equipment manufacturers.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.66% | -8.43% | -1.05% | +24.36% | +22.42% | +32.14% | +163.14% | +28.64% | +11.05% | +414.87% | +1,668.09% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 6 | 0 |
| Buy | 9 | 0 |
| Hold | 3 | -1 |
| Sell | 2 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+22.1% ★ Q1'26: +143.8% (vs Q1'25)
-
EPS growth Chemicals: +11.7%+176.7% ★ Q1'26: +595.8% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-6.1% Q1'26: +6.1% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+3.3% Q1'26: +21.6% (vs Q1'25)
-
ROIC Chemicals: +3.4%+1.1% Q1'26: +8.4% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+1.4% Q1'26: +4.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×9.41× Q1'26: 3.85× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 8 Rev. Ana. 3 EPS Ana. |
Dec 2027 15 Rev. Ana. 6 EPS Ana. |
Dec 2028 6 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.35B
est: 1.35B (+0.6%)
|
2.84B
est: 2.80B (+1.7%)
|
4.38B
est: 4.35B (+0.8%)
|
5.00B
est: 5.38B (-7.0%)
|
5.34B
est: 5.28B (+1.2%)
|
5.52B
est: 5.18B (+6.7%)
|
11.16B
est: 12.13B (-8.0%)
|
41.82B
est: 43.28B (-3.4%)
|
32.97B
est: 33.25B (-0.8%)
|
18.91B
est: 18.35B (+3.0%)
|
23.08B
est: 21.55B (+7.1%)
|
46.94B
38.95B – 61.27B
+117.8% YoY
|
53.21B
33.98B – 76.11B
+13.4% YoY
|
59.52B
43.80B – 81.35B
+11.9% YoY
|
| EBITDA |
249.15M
est: 291.59M (-14.6%)
|
879.34M
est: 605.55M (+45.2%)
|
1.59B
est: 941.63M (+69.0%)
|
1.49B
est: 1.17B (+27.6%)
|
1.00B
est: 1.14B (-12.3%)
|
1.12B
est: 1.12B (-0.3%)
|
3.84B
est: 2.63B (+46.3%)
|
18.65B
est: 9.38B (+98.9%)
|
1.23B
est: 7.20B (-83.0%)
|
1.01B
est: 3.68B (-72.6%)
|
2.82B
est: 4.32B (-34.8%)
|
9.41B
7.81B – 12.29B
+117.8% YoY
|
10.67B
6.81B – 15.27B
+13.4% YoY
|
11.94B
8.79B – 16.32B
+11.9% YoY
|
| EBIT |
169.24M
est: 242.28M (-30.1%)
|
788.50M
est: 503.15M (+56.7%)
|
1.49B
est: 782.41M (+89.8%)
|
1.34B
est: 968.21M (+38.5%)
|
778.78M
est: 949.83M (-18.0%)
|
853.09M
est: 931.69M (-8.4%)
|
3.49B
est: 2.18B (+59.8%)
|
18.16B
est: 7.79B (+133.1%)
|
374.78M
est: 5.98B (-93.7%)
|
-238.39M
est: 2.86B (-108.3%)
|
762.33M
est: 3.36B (-77.3%)
|
7.31B
6.06B – 9.54B
+117.8% YoY
|
8.29B
5.29B – 11.85B
+13.4% YoY
|
9.27B
6.82B – 12.67B
+11.9% YoY
|
| Net Income |
125.15M
est: 151.14M (-17.2%)
|
464.37M
est: 982.60M (-52.7%)
|
1.47B
est: 1.84B (-20.3%)
|
1.34B
est: 1.83B (-26.5%)
|
358.07M
est: 486.65M (-26.4%)
|
1.02B
est: 888.36M (+15.3%)
|
5.23B
est: 4.70B (+11.3%)
|
20.50B
est: 20.08B (+2.1%)
|
4.95B
est: 6.27B (-21.1%)
|
-2.07B
est: -166.95M (-1,142.3%)
|
1.61B
est: 662.26M (+143.6%)
|
7.32B
6.99B – 7.67B
+1,004.7% YoY
|
8.71B
4.95B – 15.21B
+19.0% YoY
|
9.81B
6.44B – 14.49B
+12.7% YoY
|
| SGA |
109.83M
est: 53.15M (+106.7%)
|
150.79M
est: 110.37M (+36.6%)
|
188.11M
est: 171.62M (+9.6%)
|
363.25M
est: 212.38M (+71.0%)
|
335.22M
est: 208.35M (+60.9%)
|
213.88M
est: 204.37M (+4.7%)
|
531.71M
est: 479.03M (+11.0%)
|
1.05B
est: 1.71B (-38.5%)
|
1.08B
est: 1.31B (-17.7%)
|
1.01B
est: 794.51M (+26.6%)
|
1.33B
est: 932.88M (+42.9%)
|
2.03B
1.69B – 2.65B
+117.8% YoY
|
2.30B
1.47B – 3.29B
+13.4% YoY
|
2.58B
1.90B – 3.52B
+11.9% YoY
|
| EPS |
0.08
est: 0.08 (+7.9%)
|
0.30
est: 0.49 (-38.5%)
|
0.94
est: 0.91 (+2.7%)
|
0.84
est: 0.91 (-7.1%)
|
0.32
est: 0.24 (+32.4%)
|
0.56
est: 0.44 (+27.9%)
|
2.67
est: 2.33 (+14.5%)
|
10.18
est: 9.97 (+2.1%)
|
2.46
est: 3.11 (-20.9%)
|
-1.03
est: -0.08 (-1,159.7%)
|
0.80
est: 0.32 (+146.6%)
|
3.58
3.42 – 3.76
+1,004.7% YoY
|
4.26
2.43 – 7.45
+19.0% YoY
|
4.81
3.16 – 7.10
+12.7% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C+ | 2/5 | 1/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-30 | B- | 2/5 | 1/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-29 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-15 | C+ | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Liangbin Li | Chief Executive Officer & Executive Chairman | 2M | male |
| Xiaoshen Wang | President & Vice Chairman | 2M | male |
| Haibo Shen | Executive Director | 821.0K | male |
| Sam Pigott | Head of Business Development of North America | — | male |
| Ting Huang | Vice President, Financial Director & Executive Director | — | female |
| Wing Yi Wan | Joint Company Secretary | — | female |
| Xiaofeng Luo | President of Ganfeng Lithium South America | — | male |
| Yilin Liao | Joint Company Secretary | — | female |
| Bin Wang | Vice President | — | male |
| Yuchen Ren | Secretary to the Board | — | male |
| Chenglin Li | VP & Executive Director | — | male |
| Guanghua Luo | Vice President | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002460.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
